|
ABOS Acumen Pharmaceuticals Inc 1576885 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-20,737,000.00 |
| Balance Sheet |
|
Current Assets
|
$133,094,000.00 |
|
Assets
|
$133,629,000.00 |
|
Current Liabilities
|
$29,229,000.00 |
|
Liabilities
|
$46,153,000.00 |
|
Equity
|
$87,476,000.00 |
|
Shares Out
|
72227580.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-24,128,000.00 |
|
Investing Cash Flow
|
$-13,807,000.00 |
| Market Analysis |
Market Cap
|
$156,733,848.60 |
|
Price
|
$2.13 |
|
BVPS
|
1.21 |
|
PB
|
1.79 |
|
EPS
|
-0.33 |
|
FCF
|
$-24,128,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:35 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:33 |
|
| Apr |
May |
Jun |
| 2026-03-26 |
-2.00 |
|
|
2026-05-12 |
-0.33 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-12 |
-0.68 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-12 |
-0.44 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ABOS documents filed with the SEC.
ABOS Filings
Clear
